A Randomized Double-Blind Control Trial of Intra-Articular Hyaluronic Acid:Botulinum Toxin Type a Versus Placebo for Mild to Moderate Knee Osteoarthritis

Trial Profile

A Randomized Double-Blind Control Trial of Intra-Articular Hyaluronic Acid:Botulinum Toxin Type a Versus Placebo for Mild to Moderate Knee Osteoarthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2013

At a glance

  • Drugs Botulinum toxin A (Primary) ; Hyaluronic acid (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2013 New trial record
    • 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top